These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38718434)

  • 1. Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach.
    Kumar V; Singh P; Parate S; Singh R; Ro HS; Song KS; Lee KW; Park YM
    J Mol Graph Model; 2024 Jul; 130():108789. PubMed ID: 38718434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of FAK inhibitors: a combination of 3D-QSAR, docking, and molecular dynamics simulations studies.
    Cheng P; Li J; Wang J; Zhang X; Zhai H
    J Biomol Struct Dyn; 2018 May; 36(6):1529-1549. PubMed ID: 28490269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and screening of FAK, CDK 4/6 dual inhibitors by pharmacophore model, molecular docking, and molecular dynamics simulation.
    Sun C; Feng L; Sun X; Yu R; Kang C
    J Biomol Struct Dyn; 2021 Sep; 39(15):5358-5367. PubMed ID: 32627678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHK1 kinase inhibition: identification of allosteric hits using MD simulations, pharmacophore modeling, docking and MM-PBSA calculations.
    Al-Shar'i N; Musleh SS
    Mol Divers; 2022 Apr; 26(2):903-921. PubMed ID: 33686514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
    Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
    Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction.
    Gogate PN; Ethirajan M; Kurenova EV; Magis AT; Pandey RK; Cance WG
    Eur J Med Chem; 2014 Jun; 80():154-166. PubMed ID: 24780592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.
    Wu F; Xu T; He G; Ouyang L; Han B; Peng C; Song X; Xiang M
    Int J Mol Sci; 2012 Nov; 13(12):15668-78. PubMed ID: 23443087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.
    Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H
    Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free energy calculations.
    Zhan JY; Zhang JL; Wang Y; Li Y; Zhang HX; Zheng QC
    J Biomol Struct Dyn; 2016 Nov; 34(11):2351-66. PubMed ID: 26549408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
    Rathi E; Kumar A; Kini SG
    J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of focal adhesion kinase by PIP₂ and ATP.
    Zhou J; Bronowska A; Le Coq J; Lietha D; Gräter F
    Biophys J; 2015 Feb; 108(3):698-705. PubMed ID: 25650936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
    Lu Y; Sun H
    J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of cellular-active allosteric inhibitors of FAK.
    Tomita N; Hayashi Y; Suzuki S; Oomori Y; Aramaki Y; Matsushita Y; Iwatani M; Iwata H; Okabe A; Awazu Y; Isono O; Skene RJ; Hosfield DJ; Miki H; Kawamoto T; Hori A; Baba A
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1779-85. PubMed ID: 23414845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of novel allosteric FAK inhibitors.
    Iwatani M; Iwata H; Okabe A; Skene RJ; Tomita N; Hayashi Y; Aramaki Y; Hosfield DJ; Hori A; Baba A; Miki H
    Eur J Med Chem; 2013 Mar; 61():49-60. PubMed ID: 22819505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
    Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
    Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking.
    Thiyagarajan V; Lin SH; Chang YC; Weng CF
    Biomed Pharmacother; 2016 May; 80():52-62. PubMed ID: 27133039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.